Anthera Pharmaceuticals Inc. (ANTH)

1.69
0.00 (0.00)
NASDAQ : Health Technology
Prev Close 1.69
Open 1.70
Day Low/High 1.65 / 1.84
52 Wk Low/High 1.20 / 6.24
Volume 816.90K
Avg Volume 509.40K
Exchange NASDAQ
Shares Outstanding 13.85M
Market Cap 22.02M
EPS -12.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Anthera Pharmaceuticals Announces Presentation Of Blisibimod Data At The American College Of Rheumatology Annual Meeting

Anthera Pharmaceuticals Announces Presentation Of Blisibimod Data At The American College Of Rheumatology Annual Meeting

Presentation will highlight additional analyses of the CHABLIS-SC1, Phase 3 clinical study of blisibimod

Anthera Pharmaceuticals Announces Presentation Of Blisibimod Lupus Research At The American Society Of Nephrology Annual Meeting

Anthera Pharmaceuticals Announces Presentation Of Blisibimod Lupus Research At The American Society Of Nephrology Annual Meeting

Presentation to highlight data from the CHABLIS-SC1, Phase 3 clinical study of blisibimod

Russell 2000 Skips the Party

Number of stocks making new highs keeps climbing.

DEADLINE ALERT: Brower Piven Reminds Investors Of The Upcoming Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess Of $100,000 From Investment In Anthera Pharmaceuticals, Inc. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf...